hemoglobin news

All news on hemoglobin: plants, production capacities, investments and involved companies.

11 June 2026

Johnson & Johnson’s IMAAVY shows rapid, durable hemoglobin gains in Phase 2/3 wAIHA trial

Nipocalimab 30 mg/kg produced rapid hemoglobin rises and ~3× more durable responders versus placebo at 24 weeks, with early fatigue improvement and reduced steroid use.

Who will be producing hemoglobin in the future?

Find out with chemXplore Alpha

Learn more